EquityNifty Pharma Struggles To Scale New High, Remains Range-Bound Since April: Reasons Behind StagnationBY Rishabh Raj
EquityPharma Stocks Gain Up To 5.50 Per Cent As US Outlines Plan To Lower Drug PricesBY Outlook Money
EquityNifty Pharma In Red, Dr Reddy, Lupin, Aurobindo, Sun Pharma Down Up To 3 Per Cent; Here’s WhyBY Outlook Money
